Stanford Peng

Stanford Peng

Investitore di Private Equity presso
Frazier Management LLC
55 anni
Health Technology
Consumer Services
Finance

Profilo

Stanford L.
Peng
is currently a Venture Partner at Frazier Management LLC since 2025.
Former positions include President, Head-Research & Development at Alpine Immune Sciences, Inc. from 2019 to 2024; Chief Medical Officer & Head-Clinical Development at Stemcentrx, Inc. from 2015 to 2016; Executive Director-Medical at Seagen, Inc. from 2014 to 2015; Head-Rheumatology Clinical Research Unit at Benaroya Research Institute at Virginia Mason from 2009 to 2014; Senior Director at ARYx Therapeutics, Inc. from 2008 to 2009; and Assistant Professor at Washington University School of Medicine from 2002 to 2005.
Education includes undergraduate studies at Stanford University and a doctorate from Yale School of Medicine.

Posizioni attive di Stanford Peng

SocietàPosizioneInizio
Investitore di Private Equity 01/01/2025

Precedenti posizioni note di Stanford Peng

SocietàPosizioneFine
ALPINE IMMUNE SCIENCES, INC. Presidente 20/05/2024
Direttore Tecnico/Scientifico/R&S 01/01/2016
SEAGEN INC. Direttore Tecnico/Scientifico/R&S 01/01/2015
Direttore Tecnico/Scientifico/R&S 01/01/2014
ARYX THERAPEUTICS, INC. Direttore/Membro del Consiglio 01/01/2009
Vedi nel dettaglio l'esperienza di Stanford Peng

Formazione di Stanford Peng

Esperienze
Posizioni ricoperte

Attive

Inattive

Società nel listino

Aziende private

Relazioni

37

Relazioni di 1° grado

9

Aziende connesse in 1º grado

Uomo

Donna

Amministratori

Dirigenti

Società collegate

Aziende private9

Finance

Health Technology

Health Technology

Consumer Services

Health Technology

Commercial Services

Consumer Services

Consumer Services

Health Technology

  1. Mercati
  2. Insiders
  3. Stanford Peng